Osteoactivin fragments produced by ectodomain shedding induce MMP-3 expression via ERK pathway in mouse NIH-3T3 fibroblasts

FEBS Letters

Volumn 581, Issue 30, 2007, Pages 5743-5750

  Furochi, Harumi ^a   Tamura, Seiko ^a   Mameoka, Mai ^a   Yamada, Chiharu ^a   Ogawa, Takayuki ^a   Hirasaka, Katsuya ^a   Okumura, Yuushi ^a   Imagawa, Takahito ^b   Oguri, Sachiko ^a   Ishidoh, Kazumi ^b   Kishi, Kyoichi ^a   Higashiyama, Shigeki ^c   Nikawa, Takeshi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^c EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

C2C12 myoblasts; ERK1 2; NIH 3T3 fibroblasts; Osteoactivin; Shedding

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; GLYCOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOACTIVIN; PROTEINASE INHIBITOR; STROMELYSIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FIBROBLAST; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

ANIMALS; ENZYME INDUCTION; EYE PROTEINS; FIBROBLASTS; MALE; MATRIX METALLOPROTEINASE 3; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SKELETAL; NIH 3T3 CELLS; PEPTIDE FRAGMENTS; PROTEASE INHIBITORS; PROTEIN STRUCTURE, TERTIARY; RNA, MESSENGER; UP-REGULATION;

EID: 36849076668     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.11.036     Document Type: Article

References (29)

1. Kheradmand F., and Werb Z. Shedding light on sheddases: role in growth and development. BioEssays 24 (2002) 8-12
2. Blobel C.P. ADAMs: key components in EGFR signaling and development. Nat. Rev. Mol. Cell Biol. 6 (2005) 32-43
3. Huovila A.P., Turner A.J., Pelto-Huikko M., Karkkainen I., and Ortiz R.M. Shedding light on ADAM metalloproteinases. Trend Biochem. Sci. 30 (2005) 413-422
4. Ogawa T., Nikawa T., Furochi H., Kosyoji M., Hirasaka K., Suzue N., Sairyo K., Nakano S., Yamaoka T., Itakura M., Kishi K., and Yasui N. Osteoactivin upregulates expression of MMP-3 and MMP-9 in fibroblasts infiltrated into denervated skeletal muscle in mice. Am. J. Physiol. Cell. Physiol. 289 (2005) C697-C707
5. Westermarck J., and Kahari V.M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13 (1999) 781-792
6. Musacchia X.J., Steffen J.M., and Fell R.D. Disuse atrophy of skeletal muscle: animal models. Exerc. Sport Sci. Rev. 16 (1998) 61-87
7. Muno D., Ishidoh K., Ueno T., and Kominami E. Processing and transport of the precursor of cathepsin C during its transfer into lysosomes. Arch. Biochem. Biophys. 306 (1993) 103-110
8. Ishidoh K., Saido T.C., Kawashima S., Hirose M., Watanabe S., Sato N., and Kominami E. Multiple processing of procathepsin L in vivo. Biochem. Biophys. Res. Commun. 252 (1998) 202-207
9. Nakano, S., Mishiro, T., Takahara, S., Yokoi, H., Hamada, D., Yukata, K., Takata, Y., Goto, T., Egawa, H., Yasuoka, S., Furouchi, H., Hirasaka, K., Nikawa, T. and Yasui, N. (2007) Distinct expression of mast cell tryptase and protease activated receptor-2 in synovia of rheumatoid arthritis and osteoarthritis. Clin. Rheumatol. (Epub ahead of print).
10. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
11. Nikawa T., Towatari T., and Katunuma N. Purification and characterization of cathepsin J from rat liver. Eur. J. Biochem. 204 (1992) 381-393
12. Yagami-Hiromasa T., Sato T., Kurisaki T., Kamijo K., Nabeshima Y., and Fujisawa-Sehara A. A metalloprotease-disintegrin participating in myoblast fusion. Nature 377 (1995) 652-656
13. Duffy M.J., Lynn D.J., Lioyd A.T., and O'Shea C.M. The ADAMs family of proteins: from basic studies to potential clinical applications. Thromb. Haemost. 89 (2003) 622-631
14. Garton K.J., Gough P.J., Blobel C.P., Murphy G., Greaves D.R., Dempsey P.J., and Raines E.W. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J. Biol. Chem. 276 (2001) 37993-38001
15. Fowlkes J.L., Serra D.M., Bunn R.C., Thrailkill K.M., Enghild J.J., and Nagase H. Regulation of insulin-like growth factor (IGF)-I action by matrix metalloproteinase-3 involves selective disruption of IGF-I/IGF binding protein-3 complexes. Endocrinology 145 (2004) 620-626
16. Gunja-Smith Z., Nagase H., and Woessner Jr. J.F. Purification of the neutral proteoglycan-degrading metalloproteinase from human articular cartilage tissue and its identification as stromelysin matrix metalloproteinase-3. Biochem. J. 258 (1989) 115-119
17. Bejarano P.A., Noelken M., Suzuki K., Hudson B.G., and Nagase H. Degradation of basement membranes by human matrix metalloproteinase 3 (stromelysin). Biochem. J. 256 (1988) 413-419
18. Ogata Y., Enghild J.J., and Nagase H. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J. Biol. Chem. 267 (1992) 3581-3584
19. Bullard K.M., Mudgett J.S., Scheuenstuhl H., Hunt T.K., and Banda M.J. Stromelysin-1-deficient fibroblasts display impaired contraction in vitro. J. Surg. Res. 84 (1999) 31-34
20. Bullard K.M., Lund L., Mudgett J.S., Werb Z., Mellin J.N., Hunt T.K., Murphy B., Ronan J., and Banda M.J. Impaired wound contraction in stromelysin-1 deficient mice. Ann. Surg. 230 (1999) 260-265
21. - from the oxidative burst are essential components in triggering defense gene activation and phytoalexin synthesis in parsley. Proc. Natl. Acad. Sci. USA 94 (1997) 4800-4805
22. Furochi H., Tamura S., Takeshima K., Hirasaka K., Nakao R., Kishi K., and Nikawa T. Overexpression of osteoactivin protects skeletal muscle from severe degeneration caused by long-term denervation in mice. J. Med. Invest. 54 (2007) 248-254
23. -/- microvascular endothelial cells requires prolonged activation of extracellular signal-regulated kinases-1 and -2 (ERK-1/2). J. Cell Biochem. 90 (2003) 1015-1025
24. Brogley M.A., Cruz M., and Cheung H.S. Basic calcium phosphate crystal induction of collagenase 1 and stromelysin expression is dependent on a p42/44 mitogen-activated protein kinase signal transduction pathway. J. Cell Physiol. 180 (1999) 215-224
25. Inoue T., Boyle D.L., Corr M., Hammaker D., Davis R.J., Flavell R.A., and Firestein G.S. Mitogen-activated protein kinase 3 is a pivotal pathway regulating p38 activation in inflammatory arthritis. Proc. Natl. Acad. Sci. USA 103 (2006) 5484-5489
26. Inoue T., Hammaker D., Boyle D.L., and Firestein G.S. Regulation of JNK by MKK-7 in fibroblasts-like synoviocytes. Arthritis Rheum. 54 (2006) 2127-2135
27. Kajanne, R., Miettinen, P., Mehlem, A., Leivonen, S.K., Birrer, M., Foschi, M., Kahari, V.M. and Leppa, S. (2007) EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways. J. Cell Physiol. (Epub ahead of print).
28. Lamb R.F., Hennigan R.F., Turnbull K., Katsanakis K.D., MacKenzie E.D., Birnie G.D., and Ozanne B.W. AP-1-mediated invasion requires increased expression of the hyaluronan receptor CD44. Mol. Cell Biol. 17 (1997) 963-976
29. Yee J., Kuncio G.S., Bhandari B., Shihab F.S., and Neilson E.G. Identification of promoter activity and differential expression of transcripts encoding the murine stromelysin-1 gene in renal cells. Kidney Int. 52 (1997) 120-129